BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FXYD4
,
G-protein-coupled receptor binding
,
Breast Cancer
,
Hippocampus
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tim-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Viral disease
Eating / feeding / drinking finding
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Gold
Mercuric Chloride
Antirheumatic Agents
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
xpa-1
daf-12
KDM6A
fer-1
unc-13
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
C. elegans gene expression after entrainment to 12hr light-dark and warm-cold cycles
ChIP analysis of dosage compensation complex (DCC) proteins in wildtype and DCC mutant embryos
C. elegans larvae exposed sulfidized silver nanoparticles
Starved C. elegans larvae with lin-35 mutation
Young adult N2, xpa1, and glp1 nematodes 3h after exposure to 50 J/m2 UVC radiation
Explore Curated Studies Results
Literature
Most Relevant Literature
Immune Regulation and Antitumor Effect of TIM-1.
TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection.
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.
TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver…
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Is…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participa…
Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer
Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-0…
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ